1. Targeting myeloperoxidase to stabilize unruptured aneurysm: an imaging-guided approach
- Author
-
Xingchi Shi, Yuan Xue, Huiyu Wu, Chengyi Shen, Lei Zhong, Jun Lei, Zhiyang Xia, Ying Yang, and Jiang Zhu
- Subjects
Myeloperoxidase ,Aneurysm ,Mn-TyrEDTA ,4-aminobenzoic acid hydrazide ,Metalloproteinases ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Abstract Inflammation plays a key role in pathogenesis and rupture of aneurysms. Non-invasively and dynamically monitoring aneurysm inflammation is critical. This study evaluated myeloperoxidase (MPO) as an imaging biomarker and therapeutic target for aneurysm inflammation using an elastase-induced rabbit model treated with or without 4-aminobenzoic acid hydrazide (ABAH), an irreversible inhibitor of MPO. Myeloperoxidase-sensitive magnetic resonance imaging (MRI) using Mn-TyrEDTA, a peroxidase activity-dependent contrast agent, revealed weak contrast enhancement in contralateral arteries and decreased contrast enhancement in aneurysm walls with ABAH treatment, indicating MPO activity decreased and inflammation mitigated. This was supported by reduced immune cell infiltration, matrix metalloproteinases (MMP-2 and − 9) activity, ROS production and arterial wall destruction on histology. Finally, the aneurysm expansion rate remained
- Published
- 2024
- Full Text
- View/download PDF